Clinical Trial Update: Lamivudine and Adefovir Dipivoxil Fixed Dose Combination [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a fixed-dose combination of lamivudine and adefovir dipivoxil for chronic hepatitis B has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)
• Lamivudine (lamivudine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Chronic | Phase 1 | Status: COMPLETED